Novartis, the Swiss multinational pharma giant, carried out the most clinical trials in Japan since 2012, with almost 150.
Samsung is a name readily associated with smartphones and wide-screen TVs, but the company has been broadening its horizons in recent years.
The varying result of medical studies results can make catchy headlines.
Cases of antibiotic-resistant super gonorrhea are rising rapidly according to the World Health Organization (WHO).
Alzheimer’s disease is the most common form of dementia, affecting 46.8m people worldwide.
According to information out from NHS Digital yesterday there are some 30,000 vacancies in the NHS, up 10 percent from last year.
McDonald’s, KFC, Burger King and Dixie Chicken are just some of the increasingly popular fast food chains in England.
US president Donald Trump has been repeatedly trying to pass his alternative health care bill, named the American Healthcare Act (AHCA) 2017.
Younger people – often called millennials and roughly defined as 18 to 34-year-olds – are more concerned about sun damage than older people.
Healthcare systems around the world are under unprecedented financial pressure.
India’s biggest tobacco companies have lost over $7bn in value in response to the country’s Goods and Services Tax (GST) introduced earlier this month.
Legal Lean’s new Coco Loko infused raw cacao snuff is likely to go down as one of the most controversial new product launches since Palcohol’s powdered alcohol in 2014.
Soap brand Dove — owned by Unilever — has been accused of promoting discrimination against breastfeeding in public and has been forced to pull a recent ad, with the UK advertising watchdog received 378 complaints since the campaign was launched.
The UK travel industry is campaigning against a rise in fraudulent holiday sickness claims — which has lead to warnings British tourists could be banned from some resorts.
Humira has set a record for the highest gross-selling drug in the world and contributed 63 percent to AbbVie’s revenue in 2016 alone and expectations are high the blockbuster drug will continue to perform.
When the Google DeepMind NHS partnership was launched in 2015 it was seen as an exciting new collaboration – an artificial intelligence (AI) startup working with the NHS to improve treatment for patients.
The ability to edit the human genome has been eagerly anticipated for many years.
Would you share your genetic test results with a life or health insurer if it meant a cheaper policy in return?
Drugstore giant Walgreen Boots Alliance dropped its $7.37bn takeover bid to buy US-based rival Rite Aid on Thursday.
Cancer therapy was historically dominated by chemotherapy and hormonal therapies, but now a new drug class is poised to seize a market share of more than $35bn.
Over the next few years Sanofi will go from being an also-ran in the dermatology arena to being a major player, thanks to the performance of a groundbreaking new drug.
In the lead up to the UK’s departure from the EU, efforts are being made to ensure the stability of the healthcare and pharmaceutical industries.
So far in 2017 there have been two major measles outbreaks in developed countries: one in Europe and the other in Minnesota in the US.
San Francisco has become the first city in the US to ban the sale of flavoured tobacco products, including menthol cigarettes.
Disturbing new research from the Environmental Defense Fund in the US indicates that lead is much more common in food – including baby food – than most people realise.
While uncertainty has been a theme for most sectors in the UK over recent months, the medical technology (medtech) industry has suffered more than most.
Forget drones delivering Amazon parcels, soon the flying devices could be used in medical emergencies.
A backlash against the clean eating trend is coming, linking it to unhealthy eating habits.
Almost half (49 percent) of people buy gluten-free, however perceptions of health and taste far outweigh people who buy gluten-free due to intolerance.